All cancer types
Results
Phase 1
This trial was looking at a new drug called olaparib (also known as AZD2281) for people with . It was for people who had with a change to a BRCA gene.
Recruitment start: 5 July 2008
Recruitment end: 31 August 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rhoda Molife
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 15 May 2014
CRUK internal database number: 4062
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
